SMB client The Bureau of Investigative Journalism has broken the story on Pfizer backing down on its demand that the South African government put up sovereign assets guaranteeing an indemnity against the cost of any future legal cases in return for supplies of the Pfizer vaccine. This is particularly concerning, as they have been seeking to include similar clauses in their negotiations not only with South Africa, but in countries in Latin America.
In its negotiations to provide vaccines to countries around the world, Pfizer has been asking governments to put up state owned assets as security for wide-ranging indemnity protection against any civil claims that citizens might file if they experience severe side effects from a dose of their vaccine.
This means that if Pfizer was to be sued by someone who had suffered a rare adverse effect from the vaccine then the government, not the company, would have to pay for legal costs and compensation. This would apply even if the case had been brought as a result of the company’s own acts of negligence, fraud or malice.
Stephen Shotnes supported the TBIJ on this report.
Established in 2018 by Rosalyn Breedy, our Head of Funds and Private Wealth, F21 aims to help forward-thinking businesses to take a proactive approach to embracing regulatory, economic and technological change.Read more
SMB’s Media Team have advised FAE Film and Television Limited on the production and financing of new film Save The Cinema for Sky Cinema.Read more
In a judgment handed down on Tuesday 19th January, SMB won a claim to recover the domain name blackjack.com on behalf of our client, Hanger Holdings.Read more